Core Viewpoint - Hengda Group Holdings (03616) announced a capital injection agreement involving its subsidiary Xuchang Hengda and Xuchang Municipal Investment, which will increase the registered capital of Xuchang Hengrun from RMB 100 million to RMB 160 million [1] Group 1: Capital Injection Details - Xuchang Hengda will inject RMB 24 million into Xuchang Hengrun [1] - Xuchang Municipal Investment will inject RMB 36 million into Xuchang Hengrun [1] - Post-injection, Hengda's equity in Xuchang Hengrun will be diluted from 80% to 65%, while Xuchang Municipal Investment's equity will increase from 20% to 35% [1] Group 2: Board's Perspective - The board, including independent non-executive directors, believes the terms of the capital injection are fair and reasonable [1] - The injection is conducted under normal commercial terms and aligns with the overall interests of the company and its shareholders [1] - No director has a significant interest in the injection, and no director is required to abstain from voting on the related board resolution [1]
恒达集团控股：许昌恒达拟注入许昌市恒润注册资本2400万元